Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
A61K-031/35
C07D-031/100
출원번호
US-0977365
(1997-11-24)
발명자
/ 주소
Tung Roger D.
Bhisetti Govinda Rao
출원인 / 주소
Vertex Pharmaceuticals Incorporated
대리인 / 주소
Fish & NeaveHaley, Jr.
인용정보
피인용 횟수 :
4인용 특허 :
4
초록▼
The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HI
The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods for inhibiting the activity of HIV aspartyl protease using the compounds of this invention.
대표청구항▼
[ We claim:] [1.] A compound ot formula I: [ STR 71 ] wherein: each R.sup.1 is independently selected from the group consisting of --C(O)--, --S(O).sub.2 --, --C(O)--C(O)--, --O--C(O)--, --O--S(O).sub.2 --, --NR.sup.2 --S(O).sub.2 --, --NR.sup.2 --C(O)-- and --NR.sup.2 --C(O)--C(O)--;each A is a 6 m
[ We claim:] [1.] A compound ot formula I: [ STR 71 ] wherein: each R.sup.1 is independently selected from the group consisting of --C(O)--, --S(O).sub.2 --, --C(O)--C(O)--, --O--C(O)--, --O--S(O).sub.2 --, --NR.sup.2 --S(O).sub.2 --, --NR.sup.2 --C(O)-- and --NR.sup.2 --C(O)--C(O)--;each A is a 6 membered non-aromatic monocyclic oxygenated hetercycle containing 1 endocyclic oxygen, optionally attached through a C.sub.1 -C.sub.3 alkyl linker and is fused with a 5 membered monocyclic heterocycle containing 1 endocyclic oxygen;each Ht is independently selected from the group consisting of C.sub.3 -C.sub.7 carbocycle and C.sub.6 -C.sub.10 aryl; wherein any member of said Ht is optionally substituted with one or more substituents selected from the group consisting of oxo, --OR.sup.2, --R.sup.2, --N(R.sup.2)(R.sup.2), --NHOH, --R.sup.2 --OH, --CN, --CO.sub.2 R.sup.8, --C(O)--N(R.sup.2)(R.sup.2), --S(O).sub.2 --(R.sup.2)(R.sup.2), --N(R.sup.2)--C(O)--R.sup.2, --C(O)--R.sup.2, --S(O).sub.n R.sup.2, --OCF.sub.3, S(O).sub.n --R.sup.6, --N(R.sup.2)--S(O).sub.2 (R.sup.2), halo, --CF.sub.3, --NO.sub.3, --R.sup.6, --S--CH.sub.3 and --O--R.sup.6 ;each R.sup.2 is independently selected from the group consisting of H and C.sub.1 -C.sub.3 alkyl optionally substituted with R.sup.6 ;each R.sup.3 is independently selected from the group consisting of H, Ht, C.sub.1 -C.sub.6 alkyl and C.sub.2 -C.sub.6 alkenyl wherein any member of said R.sup.3, except H, is optionally substituted with one or more substituents selected from the group consisting of --OR.sup.2, --C(O)--NH--R.sup.2, --S(O).sub.n --N(R.sup.2)(R.sup.2), Ht, --CN, --SR.sup.2, --CO.sub.2 R.sup.2 and NR.sup.2 C(O)--R.sup.2 ;each n is independently 1 or 2;each D and D' is independently selected from the group consisting of R.sup.6 ; C.sub.1 -C.sub.5 alkyl, which is optionally substituted with one or more groups selected from --OR.sup.2, --R.sup.3, --S--R.sup.6, --O--R.sup.6 and R.sup.6 ; C.sub.2 -C.sub.4 alkenyl, which is optionally substituted with one or more groups selected from the group consisting of --OR.sup.2, --R.sup.5, --O--R.sup.6 and R.sup.6 ; and C.sub.3 -C.sub.6 carbocycle, which is optionally substituted with or fused with R.sup.6 ;each E is independently selected from the group consisting of Ht; --O-Ht; Ht-Ht, --O--R.sup.3 ; --NR.sup.2 R.sup.3 ; C.sub.1 -C.sub.6 alkyl, which is optionally substituted with one or more groups selected from the group consisting of R.sup.4 and Ht; C.sub.2 -C.sub.6 alkenyl, which is optionally substituted with one or more groups selected from the group consisting of R.sup.4 and Ht; and phenyl fused with a 5-7 membered carbocycle;each R.sup.4 independently selected from the group consisting of --OR.sup.2, --C(O)--NHR.sup.2, --S(O).sub.2 --NHR.sup.2, halo, --NR.sup.2 --C(O)--R.sup.2 and --CN;each R.sup.5 is independently selected from the group consisting of H and C.sub.1 -C.sub.4 alkyl optionally substitiuted with aryl; andeach R.sup.6 is independently selected from the group consisting of aryl and carbocycle, wherein said aryl or carbocycle is optionally substituted with one or more groups selected from the qroup consisting of oxo, --OR.sup.5, --R.sup.5, --N(R.sup.5)(R.sup.5), --N(R.sup.5)--C(O)--R.sup.5, --R.sup.5 --OH, --CN, CO.sub.2 R.sup.5, --C(O)--N(R.sup.5)(R.sup.5), halo and --CF.sub.3.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (4)
Martin Joseph A. (Harpenden GB2) Redshaw Sally (Stevenage GB2), Amino acid derivatives.
Kempf Dale J. (Libertyville IL) Norbeck Daniel W. (Lindenhurst IL) Codacovi Lynn M. (Antioch IL) Plattner Jacob J. (Libertyville IL) Sham Hing L. (Gurnee IL) Zhao Chen (Gurnee IL), Retroviral protease inhibiting compounds.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.